DavidMarshallHarlanMD
Endocrinology • Worcester, MADiabetes, Lipid Metabolism
Professor of Medicine, University Mass School of Medicine
Dr. Harlan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
# Ambulato
Worcester, MA 01655Phone+1 508-334-3206Fax+1 508-856-3811
Education & Training
Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1989- Duke University HospitalResidency, Internal Medicine, 1981 - 1984
Duke University School of MedicineClass of 1980
Certifications & Licensure
MA State Medical License 2009 - 2026
CA State Medical License 1985 - 2022
NC State Medical License 1983 - 2009- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Elected Member The American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- Digital Health Tools and Behavioral Strategies to Increase Engagement With Diabetes Self-Management Education and Support: Design and Feasibility of DM-BOOST.Daniel J Amante, Lisa Shenette, Stacey Wainaina, Kavitha Balakrishnan, Shina Bhatia
The Science of Diabetes Self-Management and Care. 2024-12-01 - Herpes Simplex Virus 1 Infection of Human Brain Organoids and Pancreatic Stem Cell-Islets Drives Organoid-Specific Transcripts Associated with Alzheimer's Disease and ...Jonathan Sundstrom, Emma Vanderleeden, Nathaniel J Barton, Sambra D Redick, Pepper Dawes
Cells. 2024-11-29 - Increasing intracellular dNTP levels improves prime editing efficiency.Pengpeng Liu, Karthikeyan Ponnienselvan, Thomas Nyalile, Sarah Oikemus, Anya T Joynt
Nature Biotechnology. 2024-09-25
Lectures
- 2013 Rachmiel Levine Diabetes and Obesity SymposiumCity of Hope, Pasadena, California - 3/13/2013
- 12th Annual Rachmiel Levine Diabetes & Obesity Symposium: Advances in Diabetes ResearchCity of Hope, Pasadena, California - 2/15/2012
- Molecular Profiling of Human Pancreatic Alpha and Beta Cells in Health and DiseaseWorcester, MA - 6/15/2014
Press Mentions
First Patient-Derived Stem Cell Transplant a Success in T1DOctober 3rd, 2024- FDA Panel Supports Islet Cell Treatment for Type 1 DiabetesApril 16th, 2021
Researchers Gain Insights into Cellular Processes Associated with DiabetesMay 3rd, 2019- Join now to see all
Grant Support
- Molecular Mechanisms Underlying NHP Pancreatic Beta Cell Failure, And RecoveryNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Molecular Mechanisms Of Human And Murine Beta Cell Proliferation And RegenerationNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Transplant-Based Treatment Approaches For T1dmNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Rodent Pancreatic Islet Biology In Health And DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Preclinical Studies For Measuring Beta Cell Mass In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Novel Techniques For Assessing Beta Cell TurnoverNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Mouse Model To Assess Putative Beta Cell Progenitor CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Inpatient And Outpatient Infrastructure For T1dm Clinical ProtocolsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Immunological Mechanisms Underlying T1dm PathogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- Secondary Prevention Trials For Recently Diagnosed Type 1 Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases2009
- Diabetes Endocrinology Research Center (DERC)National Institute Of Diabetes And Digestive And Kidney Diseases2009
- Assessing A Pet-Based Technique For Characterizing Beta Cell Mass In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2009
- 03-Dk-0245 (Effect Of Ac2993 (Synthetic Exendin-4) On Pancreatic Islet Function)National Institute Of Diabetes And Digestive And Kidney Diseases2009
- Transplant-Based Treatment Approaches For T1dmNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Rodent Pancreatic Islet Biology In Health And DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Preclinical Studies For Measuring Beta Cell Mass In VivoNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Novel Techniques For Assessing Beta Cell TurnoverNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Mouse Model To Assess Putative Beta Cell Progenitor CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Inpatient And Outpatient Infrastructure For T1dm Clinical ProtocolsNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- 03-Dk-0245 (Effect Of Ac2993 (Synthetic Exendin-4) On Pancreatic Islet Function)National Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Islet Cell Transplantation For T1DM: Clinical Studies AnNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- Islet Cell Transplantation For T1dm--Clinical StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases2005
- Islet Cell Transplantation For T1DM: Clinical StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
